LAG525
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LAG525, covering 2021-04-19 to 2022-05-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer [Phase 2]